Escitalopram: all 280 studies that test it

Page 1 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive DisorderRecruitingNCT07480525Not applicable
• TDM-Guided Treatment With SSRIs in Hospitalized Adults and ChildrenRecruitingNCT07478796Phase 4
• Neuroimaging of Escitalopram in Autism Spectrum DisorderEnrolling by invitationNCT06826326Phase 2
• Effort and Antidepressant Study TestNot yet recruitingNCT06696482Phase 1/2
• Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed PeopleRecruitingNCT06675851Phase 4
• Escitalopram in Asthma Patients With Frequent ExacerbationRecruitingNCT06216535Phase 2
• Psychopharmacotherapy for Depressive PatientsRecruitingNCT06054321Not applicable
• The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingNCT05973851Phase 3
• The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.RecruitingNCT05973786Phase 3
• Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureRecruitingNCT05603104Phase 3
• Home Transcutaneous Electrical Acustimulation (TEA)RecruitingNCT05519683Phase 2/3
• Chinese Longitudinal and Systematic Study of Bioplar DisorderRecruitingNCT05480150Not applicable
• Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on AnhedoniaRecruitingNCT05389046Not applicable
• Aβ Dynamics in LLMDRecruitingNCT05004987Phase 4
• Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)RecruitingNCT04623099Phase 4
• Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)RecruitingNCT04245748Phase 4
• Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)RecruitingNCT04245436Phase 4
• Escitalopram and Language Intervention for Subacute AphasiaRecruitingNCT03843463Phase 2
• A Study Utilizing Escitalopram in Glioma PatientsRecruitingNCT03728673Phase 2
• Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on VentilationCompletedNCT05470465Phase 1Results posted
• Escitalopram to Placebo in Patients With Localized Pancreatic CancerTerminatedNCT05289830Phase 2Results posted
• Antidepressant Response in Older Adults With Comorbid PTSD and MDDTerminatedNCT04697693Phase 4Results posted
• Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in DepressionTerminatedNCT03993457Phase 4Results posted
• Investigation of Genetic Predictors of the Response to Selective Serotonin Re-uptake Inhibitors (SSRI) TreatmentCompletedNCT03927950Phase 4Results posted
• A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety DisorderCompletedNCT03924323Phase 4Results posted
• Contact: Developing New Clinical Management StrategiesCompletedNCT03812588Phase 4Results posted
• Impact of Escitalopram on Sperm DNA FragmentationTerminatedNCT03527043Phase 2Results posted
• Anxiety and Depression in Epilepsy: A Treatment StudyCompletedNCT03464383Phase 4Results posted
• Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)CompletedNCT03128021Phase 4Results posted
• Study of Neural Responses Induced by Antidepressant EffectsCompletedNCT02674529Phase 2/3Results posted
• Advancing Personalized Antidepressant Treatment Using PET/MRICompletedNCT02623205Phase 4Results posted
• SSRI Effects on Depression and Immunity in HIV/AIDSCompletedNCT02620150Phase 4Results posted
• Exercise and Pharmacotherapy for Anxiety in Cardiac PatientsCompletedNCT02516332Not applicableResults posted
• Stress and Inflammation in Late-Life DepressionCompletedNCT02389465Phase 4Results posted
• Connectivity Affecting the Antidepressant REsponse StudyCompletedNCT02332291Phase 4Results posted
• Escitalopram Effects on CSF Amyloid BetaCompletedNCT02161458Phase 4Results posted
• Developing New Clinical Management StrategiesCompletedNCT02082392Phase 4Results posted
• Mechanisms of Antidepressant Non-Response in Late-Life DepressionCompletedNCT01931202Not applicableResults posted
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive ImpairmentCompletedNCT01876823Phase 2/3Results posted
• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety SymptomCompletedNCT01870843Phase 4Results posted
• A Trial Examining the Efficacy of Escitalopram Oxalate Upon Depressive Symptoms and Fatigue in HIV Seropositive WomenTerminatedNCT01797380Phase 4Results posted
• Neurobiological Bases of Placebo Response in Major Depressive DisorderTerminatedNCT01787240Phase 4Results posted
• Emotional and Cognitive Control in Late-Onset DepressionCompletedNCT01728194Phase 4Results posted
• Brain Imaging and Treatment Studies of the Night Eating SyndromeCompletedNCT01401595Phase 3Results posted
• Influence of Escitalopram on Fear ConditioningCompletedNCT01398514Phase 4Results posted
• Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric ConditionsCompletedNCT01368432Phase 2Results posted
• Antidepressant Treatment at an Inner City Asthma ClinicCompletedNCT01324700Phase 4Results posted
• Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress DisorderCompletedNCT01271244Phase 4Results posted
• Lexapro for Major Depression in Patients With EpilepsyTerminatedNCT01244724Phase 4Results posted
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive DisorderCompletedNCT01198795Phase 4Results posted
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01123707Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111565Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111552Phase 3Results posted
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)TerminatedNCT01111539Phase 3Results posted
• Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality DisorderTerminatedNCT01103180Phase 2Results posted
• Escitalopram (Lexapro) for Depression MS or ALSCompletedNCT00965497Phase 3Results posted
• Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.TerminatedNCT00958633Phase 3Results posted
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant DepressionCompletedNCT00953745Not applicableResults posted
• Aging Brain Changes, Executive Dysfunction and DepressionCompletedNCT00918684Phase 4Results posted
• Escitalopram in Patients With Generalized Anxiety DisorderCompletedNCT00902564Phase 4Results posted
• Escitalopram in Patients With Social Anxiety DisorderCompletedNCT00902226Phase 4Results posted
• MsFLASH-01: Escitalopram for Menopausal Symptoms in Midlife WomenCompletedNCT00894543Not applicableResults posted
• Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDSCompletedNCT00887679Phase 3Results posted
• Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care UnitCompletedNCT00872027Phase 4Results posted
• Escitalopram (Lexapro) for the Treatment of Postpartum DepressionCompletedNCT00833469Phase 4Results posted
• Brain Effects of Escitalopram and Citalopram Using fMRICompletedNCT00825825Phase 4Results posted
• Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in DepressionCompletedNCT00824044Phase 4Results posted
• Early Versus Delayed Switch in Medication in Patients With Major Depressive DisorderCompletedNCT00810069Phase 4Results posted
• Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive DisorderCompletedNCT00807248Phase 2Results posted
• Treatment Response of Geriatric DepressionCompletedNCT00754936Not applicableResults posted
• Sinusitis and Facial Pain Disorders Anti-Depression TrialTerminatedNCT00754793Phase 4Results posted
• fMRI Studies of Emotional Brain Circuitry in People With Major DepressionCompletedNCT00749125Not applicableResults posted
• Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for AnxietyTerminatedNCT00746239Not applicableResults posted
• Clinical Neurobiology of Serotonin and AddictionCompletedNCT00732901Phase 2/3Results posted
• Study of Brain Response to Emotional Pictures Using a Magnetic Resonance Imaging (fMRI) While on EscitalopramCompletedNCT00707863Phase 4Results posted
• Progression Delaying Effect of Escitalopram in Alzheimer's DiseaseCompletedNCT00702780Not applicableResults posted
• Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00668525Phase 3Results posted
• Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major DepressionCompletedNCT00655057Phase 2/3Results posted
• Escitalopram Treatment of Night Eating SyndromeCompletedNCT00636649Not applicableResults posted
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive DisorderCompletedNCT00621946Phase 4Results posted
• Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older AdultsCompletedNCT00601965Not applicableResults posted
• Combining Medications to Enhance Depression OutcomesCompletedNCT00590863Phase 4Results posted
• Responses of Myocardial Ischemia to Escitalopram TreatmentCompletedNCT00574847Phase 4Results posted
• Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving TreatmentCompletedNCT00536172Phase 4Results posted
• Escitalopram for Premenstrual Syndrome (PMS) in Teens: A Pilot StudyTerminatedNCT00523705Phase 4Results posted
• Does Dual Therapy Hasten Antidepressant Response?CompletedNCT00519428Phase 4Results posted
• SSRI and BuprenorphineCompletedNCT00475878Phase 3Results posted
• Brain GABA Levels and Treatment Response in Major Depressive DisorderCompletedNCT00464711Phase 4Results posted
• Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant TreatmentCompletedNCT00456014Not applicableResults posted
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal WomenCompletedNCT00406640Phase 3Results posted
• Dichotic Listening as a Predictor of Medication Response in DepressionCompletedNCT00404755Phase 4Results posted
• Imaging Predictors of Treatment Response in DepressionCompletedNCT00367341Not applicableResults posted
• Identifying Factors That Predict Antidepressant Treatment ResponseCompletedNCT00360399Not applicableResults posted
• Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 TreatmentCompletedNCT00352885Phase 4Results posted
• Functional Dyspepsia Treatment TrialCompletedNCT00248651Phase 2/3Results posted
• Escitalopram in the Treatment of Dysthymic Disorder, Double BlindCompletedNCT00220701Phase 4Results posted
• Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)CompletedNCT00219349Phase 4Results posted
• Pilot Study to Evaluate Escitalopram in Obsessive-compulsive DisorderCompletedNCT00215137Phase 2Results posted
• Depression-Diabetes Mechanisms: Urban African AmericansCompletedNCT00209170Phase 4Results posted
• Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving EscitalopramCompletedNCT00183677Phase 4Results posted

← Escitalopram overview